ELI LILLY Aktie

 

Lilly Endowment Inc - Zehn-Prozent-Eigentümer - Tag der Transaktion: 2025-11-18...

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

read more...

Newest episode of "The Angle" from T. Rowe Price out now BALTIMORE, Nov. 19, 2025 /PRNewswire/ -- T. Rowe Price, a global investment management firm and a leader in retirement, announced the latest episode of "The Angle," an investment-themed podcast focused on timely topics shaping......

NEW YORK--(BUSINESS WIRE)--Pathway to Cures, the venture philanthropy fund of the National Bleeding Disorders Foundation (NBDF), is pleased to announce its investment in SeraGene Therapeutics, a pioneering biotechnology company dedicated to developing transformative therapies for blood coagulation disorders. SeraGene spun out from two leading blood institutes in North America, the Versiti Blood Research Institute in Wauwatosa, Wisconsin, USA, and the Center for Blood Research at the University of British Columbia in Vancouver, British Columbia, Canada, and is supported by the Nanomedicines Innovation Network (NMIN) in Canada. The company is based in Vancouver and has quickly established itself as an emerging innovator in RNA-based and nanomedicine therapies. In 2024, SeraGene was named a “Company to Watch” at the Life Sciences BC Awards and awarded the Coup de Coeur prize at Sweet Pharma Day. The company then went on to be recognized as a finalist for the prestigious Eli Lilly Grand Challenge in 2025....

INDIANAPOLIS (dpa-AFX) - Eli Lilly and Company (LLY) announced plans to open a new Lilly Gateway Labs site in Philadelphia. The new Gateway Labs site will occupy 44,000 square feet of 2300 Market,......

"Lilly Gateway Labs at Breakthrough" in Center City Will Offer Cutting-Edge Biotechnology Companies Science-Ready Suites Featuring Staffing, Programming and Amenities PHILADELPHIA, Nov. 19, 2025 /PRNewswire/ -- Breakthrough Properties today announced that it has partnered with Eli Lilly......

Gateway Labs model provides lab space and tailored scientific engagement to fuel next-generation medicines New Center City site, in partnership with Breakthrough Properties, will host a select group of early-stage biotech companies INDIANAPOLIS, Nov. 19, 2025 /PRNewswire/ -- Eli Lilly and......

These stocks both have advanced in the double-digits in recent months....

Microsoft posts strong cloud-fueled Q1 results as Azure surges and AI momentum builds, even as capacity limits pose near-term revenue constraints....

Lilly Endowment Inc - Zehn-Prozent-Eigentümer - Tag der Transaktion: 2025-11-17...

Microsoft shines in Zacks' top picks as strong cloud and AI momentum drive standout quarterly results and reinforce long-term growth potential....

The next generation of weight loss drugs will hit the market in 2026. Eli Lilly and Novo Nordisk are racing to the finish line....

New York (www.aktiencheck.de) - Eli Lilly-Aktienanalyse von J.P. Morgan Securities: Chris Schott von JPMorgan hat nach Gesprächen mit dem Management sein Kursziel für die Aktie von Eli Lilly and Company (ISIN: US5324571083, WKN: 858560, Ticker-Symbol: LLY, NYSE-Symbol: LLY) von 1.050 USD auf 1.150 USD angehoben und bestätigt sein Rating "overweight". [mehr]...

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

Lilly shines for growth seekers while J&J offers steady, lower-risk stability as both pharma giants advance pipelines and post rising estimates....

Eli Lilly shares have room to keep going as GLP-1 drugs spread their reach....

Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

Im erbitterten Konkurrenzkampf auf dem Markt für Abnehmmedikamente hat sich der dänische Pharmariese Novo Nordisk nun zu Preissenkungen auf dem Heimatmarkt des US-Rivalen entschlossen....

Pfizer's weight management pipeline just got a boost....